Myelin repair stimulated by CNS-selective thyroid hormone action
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Oligodendrocyte processes wrap axons to form neuroprotective myelin sheaths, and damage to myelin in disorders, such as multiple sclerosis (MS), leads to neurodegeneration and disability. There are currently no approved treatments for MS that stimulate myelin repair. During development, thyroid hormone (TH) promotes myelination through enhancing oligodendrocyte differentiation; however, TH itself is unsuitable as a remyelination therapy due to adverse systemic effects. This problem is overcome with selective TH agonists, sobetirome and a CNS-selective prodrug of sobetirome called Sob-AM2. We show here that TH and sobetirome stimulated remyelination in standard gliotoxin models of demyelination. We then utilized a genetic mouse model of demyelination and remyelination, in which we employed motor function tests, histology, and MRI to demonstrate that chronic treatment with sobetirome or Sob-AM2 leads to significant improvement in both clinical signs and remyelination. In contrast, chronic treatment with TH in this model inhibited the endogenous myelin repair and exacerbated disease. These results support the clinical investigation of selective CNS-penetrating TH agonists, but not TH, for myelin repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation
Back, S. A., Tuohy, T. M. F., Chen, H., Wallingford, N., Craig, A., Struve, J., Luo, N. L., Banine, F., Liu, Y., Chang, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1279 · Cited by 612 · cited 1×
“To induce focal demyelination, we injected lysolecithin (2%) into the corpus callosum (Figure 2A and Supplemental Figure 2, A and B) (30) and initiated once-daily injections with vehicle, T3 (1 mg/kg/d, i.”
MethodWolswijk, G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00601.1998 · Cited by 562
Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination
Emery, B., Agalliu, D., Cahoy, J. D., Watkins, T. A., Dugas, J. C., Mulinyawe, S. B., Ibrahim, A., Ligon, K. L., Rowitch, D. H., & Barres, B. A. (2009) · Cell · doi:10.1016/j.cell.2009.04.031 · Cited by 559 · cited 2×
“As Myrf is not required for Schwann cell myelination in the peripheral nervous system (32, 33), these motor performance deficits presumably reflected the effects of CNS demyelination.”
BackgroundMethodSelf-citationA regenerative approach to the treatment of multiple sclerosis
Deshmukh, V. A., Tardif, V., Lyssiotis, C. A., Green, C. C., Kerman, B., Kim, H. J., Padmanabhan, K., Swoboda, J. G., Ahmad, I., Kondo, T., et al. (2013) · Nature · doi:10.1038/nature12647 · Cited by 531
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
Najm, F. J., Madhavan, M., Zaremba, A., Shick, E., Karl, R. T., Factor, D. C., Miller, T. E., Nevin, Z. S., Kantor, C., Sargent, A., et al. (2015) · Nature · doi:10.1038/nature14335 · Cited by 424
Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination
Hubler, Z., Allimuthu, D., Bederman, I., Elitt, M. S., Madhavan, M., Allan, K. C., Shick, H. E., Garrison, E., T. Karl, M., Factor, D. C., et al. (2018) · Nature · doi:10.1038/s41586-018-0360-3 · Cited by 237 · cited 1×
“traditional demyelination rodent models and mechanisms of action that may explain pro-remyelinating properties have been identified post-hoc (40, 41).”
BackgroundBianco, A. C., Anderson, G., Forrest, D., Galton, V. A., Gereben, B., Kim, B. W., Kopp, P. A., Liao, X. H., Obregon, M. J., Peeters, R. P., et al. (2014) · Thyroid · doi:10.1089/thy.2013.0109 · Cited by 205 · cited 1×
“Either hypo- or hyperthyroidism was induced in iCKO-Myrf mice using standard pharmacological methods (37) 2 weeks after tamoxifen injections, and the altered thyroid status was maintained until the conclusion of the experiment.”
MethodTraka, M., Arasi, K., Avila, R. L., Podojil, J. R., Christakos, A., Miller, S. D., Soliven, B., & Popko, B. (2010) · Brain · doi:10.1093/brain/awq247 · Cited by 118 · cited 1×
“A genetic model of demyelination based on diphtheria toxin–induced oligodendrocyte cell death showed widespread CNS demyelination followed by near-complete recovery with 10 weeks (51), but this model has not been used to evaluate myelin repair agents.”
MethodSpatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model
Tagge, I., O’Connor, A., Chaudhary, P., Pollaro, J., Berlow, Y., Chalupsky, M., Bourdette, D., Woltjer, R., Johnson, M., & Rooney, W. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152480 · Cited by 81
Self-citation
Cited by
Remyelination in multiple sclerosis: From basic science to clinical translation
Lubetzki, C., Zalc, B., Williams, A., Stadelmann, C., & Stankoff, B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30140-x · Cited by 350
Groeneweg, S., van Geest, F. S., Peeters, R. P., Heuer, H., & Visser, W. E. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz008 · Cited by 216
Saponaro, F., Sestito, S., Runfola, M., Rapposelli, S., & Chiellini, G. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00331 · Cited by 124
“Finally, the same group demonstrated that it was possible to show and monitor the GC-1 induced oligodendrogenesis in the corpus callosum, occipital cortex and optic nerve using an in-vivo transgenic mouse model (73, 84).”
Sawicka-Gutaj, N., Zawalna, N., Gut, P., & Ruchała, M. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00377-w · Cited by 57
“Thyreomimetics significantly alleviated clinical symptoms and improved remyelination, while THs led to exacerbation of the disease and inhibition of myelin repair [145].”
BackgroundRemyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
Packer, D., Fresenko, E. E., & Harrington, E. P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1207007 · Cited by 21
Metadata
- Authors
- Hartley, M. D., Banerji, T., Tagge, I. J., Kirkemo, L. L., Chaudhary, P., Calkins, E., Galipeau, D., Shokat, M. D., DeBell, M. J., Van Leuven, S., Miller, H., Marracci, G., Pocius, E., Banerji, T., Ferrara, S. J., Meinig, J. M., Emery, B., Bourdette, D., & Scanlan, T. S.
- Venue
- JCI Insight
- Published
- 2019-04-18
- Volume
- 4
- Issue
- 8
- ISSN
- 2379-3708 (ISSN-L)
- OpenAlex
- W2935974898
- Cited by
- 104
- References
- 9
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myelin repair stimulated by CNS-selective thyroid hormone action. https://app.cochat.ai/papers/10.1172/jci.insight.126329
- The paper
- Hartley, M. D., Banerji, T., Tagge, I. J., Kirkemo, L. L., Chaudhary, P., Calkins, E., Galipeau, D., Shokat, M. D., DeBell, M. J., Van Leuven, S., Miller, H., Marracci, G., Pocius, E., Banerji, T., Ferrara, S. J., Meinig, J. M., Emery, B., Bourdette, D., & Scanlan, T. S. (2019). Myelin repair stimulated by CNS-selective thyroid hormone action. JCI Insight. https://doi.org/10.1172/jci.insight.126329
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.